<DOC>
	<DOC>NCT02221297</DOC>
	<brief_summary>Purpose of the study is to determine the effect of the investigational products as consumed with a meal on serum lipids, primarily on LDL cholesterol.</brief_summary>
	<brief_title>Lipid-lowering Effect of a Plant Stanol Ester Supplement Product</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Hyperlipidemias</mesh_term>
	<criteria>male and female over 18 years old serum LDL cholesterol &gt; 3.0 mmol/L BMI &lt; 35 subjects must voluntarily sign the informed consent subjects using lipid lowering medication (ezetimibe, bile acid sequestrant, statin therapy) subjects with any hepatic or renal disorder according to medical history subjects who have history of myocardial infarction or unstable angina pectoris within six months prior to screening subjects who have history of coronary artery bypass graft or percutaneous transluminal coronary angioplasty within six months prior to screening subjects who have history of temporal ischemic attack or stroke within six months prior to screening subjects who have a history of cancer or other malignant disease within the past five years subjects who are consuming more than 15 portions of alcohol / week subjects who are pregnant or lactating subjects using cholesterollowering foods or dietary supplements within 14 days before start of the intervention subjects with intolerance to any ingredient of the test product</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>